Jump to content

Focal hyperhidrosis: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
whoops
update ref
Line 27: Line 27:
Focal hyperhidrosis can have a significant impact on quality of life. Individuals can be affected from a social, psychological, emotional and professional perspective.<ref name="Solish et al 2007">{{cite journal|last1=Solish|first1=Nowell|last2=Bertucci|first2=Vince|last3=Dansereau|first3=Alain|last4=Hong|first4=H. Chih-ho|last5=Lynde|first5=Charles|last6=Lupin|first6=Mark|last7=Smith|first7=Kevin C.|last8=Storwick|first8=Greg|display-authors=1|year=2007|title=A Comprehensive Approach to the Recognition, Diagnosis, and Severity-Based Treatment of Focal Hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee|journal=Dermatologic Surgery|volume=33|pages=908–923|doi=10.1111/j.1524-4725.2007.33192.x|pmid=17661933}}</ref> The condition has been referred to as "The Silent Handicap" for this reason.<ref>{{cite journal|last1=Swartling|first1=Carl|last2=Brismar|first2=Kerstin|last3=Aquilonius|first3=Sten-Magnus|last4=Naver|first4=Hans|last5=Rystedt|first5=Alma|last6=Rosell|first6=Karolina|display-authors=1|year=2011|title=Hyperhidros - det "tysta" handikappet|language=Swedish|journal=Läkartidningen|volume=108|issue=47|pages=2428–2432}}</ref> The Canadian Hyperhidrosis Advisory Committee has published a comprehensive set of guidelines which outlines key aspects of treatment related to this condition. Topical hyperhidrosis gels containing aluminum chloride hexahydrate are usually first choice treatments for this condition.<ref name="Solish et al 2007" />
Focal hyperhidrosis can have a significant impact on quality of life. Individuals can be affected from a social, psychological, emotional and professional perspective.<ref name="Solish et al 2007">{{cite journal|last1=Solish|first1=Nowell|last2=Bertucci|first2=Vince|last3=Dansereau|first3=Alain|last4=Hong|first4=H. Chih-ho|last5=Lynde|first5=Charles|last6=Lupin|first6=Mark|last7=Smith|first7=Kevin C.|last8=Storwick|first8=Greg|display-authors=1|year=2007|title=A Comprehensive Approach to the Recognition, Diagnosis, and Severity-Based Treatment of Focal Hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee|journal=Dermatologic Surgery|volume=33|pages=908–923|doi=10.1111/j.1524-4725.2007.33192.x|pmid=17661933}}</ref> The condition has been referred to as "The Silent Handicap" for this reason.<ref>{{cite journal|last1=Swartling|first1=Carl|last2=Brismar|first2=Kerstin|last3=Aquilonius|first3=Sten-Magnus|last4=Naver|first4=Hans|last5=Rystedt|first5=Alma|last6=Rosell|first6=Karolina|display-authors=1|year=2011|title=Hyperhidros - det "tysta" handikappet|language=Swedish|journal=Läkartidningen|volume=108|issue=47|pages=2428–2432}}</ref> The Canadian Hyperhidrosis Advisory Committee has published a comprehensive set of guidelines which outlines key aspects of treatment related to this condition. Topical hyperhidrosis gels containing aluminum chloride hexahydrate are usually first choice treatments for this condition.<ref name="Solish et al 2007" />


In addition to topical [[antiperspirants]] main active ingredients usually being aluminum or zirconium salts) treatment options include: [[iontophoresis]] (hands, feet), onabotulinumtoxinA ([[Botox]]) injections (underarms, hands, feet, and other localized areas),<ref>{{cite journal |vauthors=Walling HW, Swick BL | year = 2011 | title = Treatment options for hyperhidrosis | url = | journal = Am J Clin Dermatol | volume = 12 | issue = 5| pages = 285–295 }}</ref> electromagnetic/microwave energy [[thermolysis]] of underarm sweat glands,<ref>{{cite journal|last1=Jacob|first1=C|title=Treatment of hyperhidrosis with microwave technology.|journal=Seminars in cutaneous medicine and surgery|date=March 2013|volume=32|issue=1|pages=2-8|pmid=24049923}}</ref> laser-assisted removal of the sweat glands (underarms),<ref name=2014rev>{{cite journal|last1=Brown|first1=AL|last2=Gordon|first2=J|last3=Hill|first3=S|title=Hyperhidrosis: review of recent advances and new therapeutic options for primary hyperhidrosis.|journal=Current opinion in pediatrics|date=August 2014|volume=26|issue=4|pages=460-5|pmid=24905102}}</ref> other local procedures such as liposuction and curettage of the sweat glands (underarms), oral prescription medications/anticholinergics, and surgery for sweating of the hands or head that can't be controlled by other means.<ref name=2014rev/>
In addition to topical [[antiperspirants]] main active ingredients usually being aluminum or zirconium salts) treatment options include: [[iontophoresis]] (hands, feet), onabotulinumtoxinA ([[Botox]]) injections (underarms, hands, feet, and other localized areas),<ref name=Stashak2014rev>{{cite journal|last1=Stashak|first1=AB|last2=Brewer|first2=JD|title=Management of hyperhidrosis.|journal=Clinical, cosmetic and investigational dermatology|date=29 October 2014|volume=7|pages=285-99|pmid=25378942|pmc=4218921}}</ref> electromagnetic/microwave energy [[thermolysis]] of underarm sweat glands,<ref>{{cite journal|last1=Jacob|first1=C|title=Treatment of hyperhidrosis with microwave technology.|journal=Seminars in cutaneous medicine and surgery|date=March 2013|volume=32|issue=1|pages=2-8|pmid=24049923}}</ref> laser-assisted removal of the sweat glands (underarms),<ref name=2014rev>{{cite journal|last1=Brown|first1=AL|last2=Gordon|first2=J|last3=Hill|first3=S|title=Hyperhidrosis: review of recent advances and new therapeutic options for primary hyperhidrosis.|journal=Current opinion in pediatrics|date=August 2014|volume=26|issue=4|pages=460-5|pmid=24905102}}</ref> other local procedures such as liposuction and curettage of the sweat glands (underarms), oral prescription medications/anticholinergics, and surgery for sweating of the hands or head that can't be controlled by other means.<ref name=2014rev/>


==References==
==References==

Revision as of 02:56, 25 October 2016

Focal hyperhidrosis

Focal hyperhidrosis is a condition characterized by excessive or profuse sweating in certain body regions. It is also referred to as primary hyperhidrosis. Unlike its counterpart, that is, generalized or secondary hyperhidrosis, it is idiopathic in nature or is not associated with an underlying condition. Typical regions of excessive sweating include the underarms, palms, soles, groin and craniofacial (face/scalp) areas. Sweating patterns are typically bilateral or symmetric and rarely occur in just one palm or one underarm. Night sweats or sweating while sleeping is also rare. The onset of focal hyperhidrosis is usually before the age of 25 years. This is in contrast to generalized hyperhidrosis which tends to occur in an older age group. Evidence demonstrates that a positive family history is also present.[1]

The condition occurs in approximately 3% of the general population. Prevalence among men and woman is relatively the same. Profuse sweating is present mostly in the underarms, followed by the feet, palms and facial region.[2]

Focal hyperhidrosis can have a significant impact on quality of life. Individuals can be affected from a social, psychological, emotional and professional perspective.[3] The condition has been referred to as "The Silent Handicap" for this reason.[4] The Canadian Hyperhidrosis Advisory Committee has published a comprehensive set of guidelines which outlines key aspects of treatment related to this condition. Topical hyperhidrosis gels containing aluminum chloride hexahydrate are usually first choice treatments for this condition.[3]

In addition to topical antiperspirants main active ingredients usually being aluminum or zirconium salts) treatment options include: iontophoresis (hands, feet), onabotulinumtoxinA (Botox) injections (underarms, hands, feet, and other localized areas),[5] electromagnetic/microwave energy thermolysis of underarm sweat glands,[6] laser-assisted removal of the sweat glands (underarms),[7] other local procedures such as liposuction and curettage of the sweat glands (underarms), oral prescription medications/anticholinergics, and surgery for sweating of the hands or head that can't be controlled by other means.[7]

References

  1. ^ Walling, Hobart W. (2011). "Clinical differentiation of primary from secondary hyperhidrosis". Journal of the American Academy of Dermatology. 64 (4): 690–695. doi:10.1016/j.jaad.2010.03.013.
  2. ^ Haider, Aamir; Solish, Nowell (2005). "Focal hyperhidrosis: diagnosis and management". Canadian Medical Association Journal. 172 (1): 69–75. doi:10.1503/cmaj.1040708. PMC 543948. PMID 15632408. {{cite journal}}: Unknown parameter |lastauthoramp= ignored (|name-list-style= suggested) (help)
  3. ^ a b Solish, Nowell; et al. (2007). "A Comprehensive Approach to the Recognition, Diagnosis, and Severity-Based Treatment of Focal Hyperhidrosis: Recommendations of the Canadian Hyperhidrosis Advisory Committee". Dermatologic Surgery. 33: 908–923. doi:10.1111/j.1524-4725.2007.33192.x. PMID 17661933.
  4. ^ Swartling, Carl; et al. (2011). "Hyperhidros - det "tysta" handikappet". Läkartidningen (in Swedish). 108 (47): 2428–2432.
  5. ^ Stashak, AB; Brewer, JD (29 October 2014). "Management of hyperhidrosis". Clinical, cosmetic and investigational dermatology. 7: 285–99. PMC 4218921. PMID 25378942.
  6. ^ Jacob, C (March 2013). "Treatment of hyperhidrosis with microwave technology". Seminars in cutaneous medicine and surgery. 32 (1): 2–8. PMID 24049923.
  7. ^ a b Brown, AL; Gordon, J; Hill, S (August 2014). "Hyperhidrosis: review of recent advances and new therapeutic options for primary hyperhidrosis". Current opinion in pediatrics. 26 (4): 460–5. PMID 24905102.